🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to evaluate the efficacy of 3 subcut...
Status
Completed
Location
Research Site
Start Date
2012-08
Trial ID
NCT01706926
Treatments Being Tested
This study is a prospective, phase II, multi-center, randomized, double-bli...
Status
Unknown
Location
IRCCS Policlinico San Donato
Start Date
2020-05-22
Trial ID
NCT04397497
Treatments Being Tested
A clinical study to investigate the safety of mavrilimumab, an antibody bei...
Status
Terminated
Location
Research Site
Start Date
2013-01-28
Trial ID
NCT01712399
Treatments Being Tested
The purpose of this prospective, Phase 2, multicenter, blinded, randomized ...
Status
Completed
Location
University of Cincinnati
Start Date
2020-05-20
Trial ID
NCT04492514
Treatments Being Tested
The primary objectives of this study is to assess the safety, tolerability ...
Status
Completed
Location
Research Site
Start Date
2010-01-05
Trial ID
NCT01050998
Treatments Being Tested
Interventional, randomized, double-blind, placebo-controlled study encompas...
Status
Completed
Location
UCLA Medical Center
Start Date
2020-07-28
Trial ID
NCT04447469
Treatments Being Tested
The primary objectives of this study is to explore the efficacy of mavrilim...
Status
Completed
Location
Research Site
Start Date
2013-03
Trial ID
NCT01715896
Treatments Being Tested
The primary objective of the study is to evaluate the efficacy of mavrilimu...
Status
Completed
Location
Site 1703
Start Date
2018-09-20
Trial ID
NCT03827018
Treatments Being Tested
The purpose of this prospective, Phase 2, multicenter, blinded, randomized ...
Status
Completed
Location
Cleveland Clinic Florida
Start Date
2020-05-20
Trial ID
NCT04399980
Treatments Being Tested
The purpose of this prospective, Phase 2, multicenter, blinded, randomized ...
Status
Completed
Location
Virginia Commonwealth University
Start Date
2020-09-02
Trial ID
NCT04463004
Treatments Being Tested